Perrigo Chairman Joseph Papa Unloads 15,000 Shares (PRGO)
Perrigo (NASDAQ:PRGO) Chairman Joseph Papa sold 15,000 shares of the company’s stock in a transaction dated Tuesday, September 24th. The shares were sold at an average price of $124.60, for a total value of $1,869,000.00. Following the completion of the transaction, the chairman now directly owns 116,655 shares in the company, valued at approximately $14,535,213. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Perrigo (NASDAQ:PRGO) traded down 0.21% during mid-day trading on Thursday, hitting $122.88. 325,558 shares of the company’s stock traded hands. Perrigo has a 52 week low of $98.79 and a 52 week high of $134.31. The stock has a 50-day moving average of $123.1 and a 200-day moving average of $121.2. The company has a market cap of $11.564 billion and a P/E ratio of 26.31.
Perrigo (NASDAQ:PRGO) last released its earnings data on Thursday, August 15th. The company reported $1.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.56 by $0.01. The company had revenue of $967.20 million for the quarter, compared to the consensus estimate of $999.08 million. During the same quarter in the previous year, the company posted $1.28 earnings per share. The company’s revenue for the quarter was up 16.3% on a year-over-year basis. Analysts expect that Perrigo will post $6.56 EPS for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo (NASDAQ:PRGO) in a research note to investors on Wednesday, September 18th. They now have a $131.00 price target on the stock. Separately, analysts at CRT Capital initiated coverage on shares of Perrigo (NASDAQ:PRGO) in a research note to investors on Tuesday, September 17th. They set a “buy” rating and a $145.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Perrigo presently has an average rating of “Buy” and a consensus price target of $130.77.
Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products and active pharmaceutical ingredients (API).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.